Public Preference for Off-Label Use of Drugs for Cancer Treatment and Relative Importance of Associated Adverse Events: A Discrete Choice Experiment and Best-Worst Scaling

2024-9-10

Comparison of Caregiver and General Population Preferences for Dependency-Related Health States

2024-9-10

Are Drug Novelty Characteristics Associated With Greater Health Benefits?

2024-9-3

Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers

2024-9-2

Impact of Government-Funded Health Insurance on Out-of-Pocket Expenditure and Quality of Hospital-Based Care in Indian States of Madhya Pradesh and Maharashtra

2024-8-25

A Contingent Valuation Study for Use in Valuing Public Goods with Health Externalities: The Case of Street Pianos

2024-8-20

Economic Epidemiology: A Framework to Study Interactions of Epidemics and the Economy

2024-8-14

Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland

2024-8-12

The Development of a New Approach for the Harmonized Multi-Sectoral and Multi-Country Cost Valuation of Services: The PECUNIA Reference Unit Cost (RUC) Templates

2024-8-8

Financial Literacy and Mental Health: Empirical Evidence from China

2024-7-30

Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance

2024-7-26

The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review

2024-7-17

Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective

2024-7-13

Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges

2024-7-12

How is Value Defined in Molecular Testing in Cancer? A Scoping Review

2024-7-9

A Multi-dimensional Framework of Valued Output for Primary Care in England

2024-7-6

Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review

2024-7-4

Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment

2024-7-1

Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments

2024-6-25

How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry

2024-6-15

Cost of Carbon in the Total Cost of Healthcare Procedures: A Methodological Challenge

2024-6-11

The Cost-Effectiveness of Primary Prevention Interventions for Skin Cancer: An Updated Systematic Review

2024-6-11

Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand

2024-6-10

Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally

2024-6-5

Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa

2024-5-25

Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit

2024-5-21

Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden

2024-5-17

A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening

2024-5-16

Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis

2024-5-10

Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study

2024-4-29

Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China

2024-4-19

Health Economics in a World of Uneconomic Growth

2024-4-18

Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis

2024-4-10

Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment

2024-3-30

The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities

2024-3-26

Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study

2024-3-11

Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India

2024-3-7

#SharingHEOR: Developing Modern Media for Communication and Dissemination of Health Economics and Outcomes Research

2024-3-1

Cost of Low-Value Imaging Worldwide: A Systematic Review

2024-3-1

The Impact of Raising Alcohol Taxes on Government Tax Revenue: Insights from Five European Countries

2024-2-22

Simplified Methods for Modelling Dependent Parameters in Health Economic Evaluations: A Tutorial

2024-2-20

Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?

2024-2-8

Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations

2024-2-5

What Interventions are Cost Effective in Reducing Violence Against Women? A Scoping Review

2024-1-27

Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana

2024-1-24

Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective

2024-1-23

Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA

2024-1-22

Are Web-Based Valuation Surveys for Preference-Based Measures as Reliable as Face-to-Face Surveys? TTO, DCE and DCE with Duration

2024-1-13

Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance

2024-1-12

A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries

2024-1-12